Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, Canada

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–1210. doi:10.1016/S0140-6736(17)32152-928919116
   PubMed Web of Science ®Google Scholar
• Evans J, Chen Y, Camp PG, Bowie DM, McRae L. Estimating the prevalence of COPD in Canada: reported diagnosis versus measured airflow obstruction. Health Rep. 2014;25:3–11.
   PubMed Web of Science ®Google Scholar
• Statistics Canada. Chronic obstructive pulmonary disease under-diagnosed in Canadian adults: results from cycles 3 and 4 (2012 to 2015) of the Canadian Health Measures Survey. Available from: http://www.statcan.gc.ca/pub/82-625-x/2017001/article/14701-eng.htm. Accessed 1213, 2017.
   Google Scholar
• Statistics Canada. Table: 17-10-0057-01 (formerly CANSIM 052-0005) – projected population, by projection scenario, age and sex, as of July 1 (x 1,000). Available from: http://www5.statcan.gc.ca/cansim/pick-choisir?lang=eng&p2=33&id=0520005. Accessed 27, 2018.
   Google Scholar
• Bourbeau J, Bhutani M, Hernandez P, et al. CTS position statement: pharmacotherapy in patients with COPD – an update. Can J Respir Crit Care Sleep Med. 2017;1:222–241. doi:10.1080/24745332.2017.1395588
   Web of Science ®Google Scholar
• Falk J, Dik N, Bugden S. An evaluation of early medication use for COPD: a population-based cohort study. Int J Chron Obstruct Pulmon Dis. 2016;11:3101–3108. doi:10.2147/COPD.S12364327994449
   PubMed Web of Science ®Google Scholar
• Ford ES, Mannino DM, Giles WH, Wheaton AG, Liu Y, Croft JB. Prescription practices for chronic obstructive pulmonary disease: findings from the national ambulatory medical care survey 1999-2010. COPD. 2014;11:247–255. doi:10.3109/15412555.2013.84057024568285
   PubMedGoogle Scholar
• Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J. 2008;15:13–19. doi:10.1155/2008/17390418292848
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen TS, Marott JL, Nordestgaard BG, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30:51–59. doi:10.1007/s11606-014-3029-025245885
   PubMed Web of Science ®Google Scholar
• Alberta Health. Overview of administrative health datasets. Available from: https://open.alberta.ca/dataset/657ed26d-eb2c-4432-b9cb-0ca2158f165d/resource/38f47433-b33d-4d1e-b959-df312e9d9855/download/Research-Health-Datasets.pdf. Accessed 121, 2017.
   Google Scholar
• Tran DT, Ohinmaa A, Thanh NX, Welsh RC, Kaul P. The healthcare cost burden of acute myocardial infarction in Alberta, Canada. Pharmacoecon Open. 2017;2:433–442. doi:10.1007/s41669-017-0061-0
   Web of Science ®Google Scholar
• Islam S, Kaul P, Tran DT, Mackie AS. Health care resource utilization among children with congenital heart disease: a population-based study. Can J Cardiol. 2018;34:1289–1297. doi:10.1016/j.cjca.2018.06.01130205987
   PubMed Web of Science ®Google Scholar
• Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD. 2009;6:388–394. doi:10.1080/1541255090314086519863368
   PubMedGoogle Scholar
• Tran DT, Thanh NX, Ohinmaa A, Mayers I, Jacobs P. Current and future direct healthcare cost burden of chronic obstructive pulmonary disease in Alberta, Canada. Can J Respir Crit Care Sleep Med. 2019;1–9.
   Web of Science ®Google Scholar
• Health Canada. Drug Product Database Online Query. Ottawa, Ontario, Canada: Health Canada; 2017.
   Google Scholar
• Alberta Health. Interactive drug benefit list. Available from: https://www.ab.bluecross.ca/dbl/publications.html. Accessed 510, 2018.
   Google Scholar
• Fromer L, Cooper CB. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD. Int J Clin Pract. 2008;62:1219–1236. doi:10.1111/j.1742-1241.2008.01807.x18547365
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy For The Diagnosis, Management, And Prevention Of Chronic Obstructive Pulmonary Disease. Vol. 2006 Geneva, Switzerland: World Health Organization; 2006.
   Google Scholar
• O’Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 update. Can Respir J. 2007;14 Suppl B:5b–32b. doi:10.1155/2007/830570
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2008 update - highlights for primary care. Can Respir J. 2008;15 Suppl A:1a–8a.
   PubMed Web of Science ®Google Scholar
• University of Alberta Libraries. Data library. 2010 Census of Canada. 2012.
   Google Scholar
• Statistics Canada. Postal code conversion file (PCCF), reference guide. Available from: https://www150.statcan.gc.ca/n1/pub/92-153-g/2011002/tech-eng.htm. Accessed 22, 2019
   Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139. doi:10.1097/01.mlr.0000182534.19832.8316224307
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen TS, Marott JL, Vestbo J, et al. Characteristics of undertreatment in COPD in the general population. Chest. 2013;144:1811–1818. doi:10.1378/chest.13-045323989916
   PubMed Web of Science ®Google Scholar
• Bryant J, McDonald VM, Boyes A, Sanson-Fisher R, Paul C, Melville J. Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res. 2013;14:109. doi:10.1186/1465-9921-14-1924138097
   PubMed Web of Science ®Google Scholar
• Wu R, Liaqat D, de Lara E, et al. Feasibility of using a smartwatch to intensively monitor patients with chronic obstructive pulmonary disease: prospective cohort study. JMIR mHealth uHealth. 2018;6:e10046. doi:10.2196/1004629903700
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003;163:585–591. doi:10.1001/archinte.163.5.58512622605
   PubMed Web of Science ®Google Scholar
• Lenferink A, van der Palen J, Effing T. The role of social support in improving chronic obstructive pulmonary disease self-management. Expert Rev Respir Med. 2018;1–4.
   Web of Science ®Google Scholar
• Lipson DA, Barnhart F, Brealey N, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378:1671–1680. doi:10.1056/NEJMoa171390129668352
   PubMed Web of Science ®Google Scholar
• Papi A, Vestbo J, Fabbri L, et al. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet. 2018;391:1076–1084. doi:10.1016/S0140-6736(18)30206-X29429593
   PubMed Web of Science ®Google Scholar
• Singh S, Loke YK. Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update. Curr Opin Pulm Med. 2010;16:118–122. doi:10.1097/MCP.0b013e328334c08519926996
   PubMed Web of Science ®Google Scholar
• Tariq SM, Thomas EC. Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers? Int J Chron Obstruct Pulmon Dis. 2017;12:1877–1882. doi:10.2147/COPD.S13800628694698
   PubMed Web of Science ®Google Scholar
• Al-Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med. 2007;101:2395–2401. doi:10.1016/j.rmed.2007.06.00817629471
   PubMed Web of Science ®Google Scholar
• Murio C, Soler X, Perez M, Calero G, Ruiz-Manzano J. Acute exacerbation of chronic obstructive pulmonary disease in primary care setting in Spain: the EPOCAP study. Ther Adv Respir Dis. 2010;4:215–223. doi:10.1177/175346581037461120624789
   PubMedGoogle Scholar
• Llor C, Bjerrum L, Munck A, et al. Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice. Ther Adv Respir Dis. 2013;7:131–137. doi:10.1177/175346581247238723325784
   PubMed Web of Science ®Google Scholar
• Llor C, Moragas A, Hernandez S, Bayona C, Miravitlles M. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:716–723. doi:10.1164/rccm.201206-0996OC22923662
   PubMed Web of Science ®Google Scholar
• Butorac-Petanjek B, Parnham MJ, Popovic-Grle S. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD). J Chemother. 2010;22:291–297. doi:10.1179/joc.2010.22.5.29121123150
   PubMed Web of Science ®Google Scholar
• Huckle AW, Fairclough LC, Todd I. Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics. Respir Care. 2018;63:609–619. doi:10.4187/respcare.0594329463692
   PubMed Web of Science ®Google Scholar
• Brett AS, Al-Hasan MN. COPD exacerbations – a target for antibiotic stewardship. N Engl J Med. 2019;381:174–175. doi:10.1056/NEJMe190552031291521
   PubMed Web of Science ®Google Scholar
• Serisier DJ. Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases. Lancet Respir Med. 2013;1:262–274. doi:10.1016/S2213-2600(13)70038-924429132
   PubMed Web of Science ®Google Scholar